Chief Medical Officer

Professor Barua is a neurosurgeon specialising in brain tumor surgery (Neuro-oncology) and has fellowship training in Stereotactic and Functional Neurosurgery.  He is currently lead for neuro-oncology surgery at North Bristol NHS Trust. ​

Professor Barua completed his PhD in drug delivery to the brain in 2013 and has worked on several translational research programmes investigating convection enhanced drug (CED) delivery for neurodegenerative and neuro-oncological diseases. This includes a phase 1b/2a clinical trial of GDNF for Parkinson’s Disease, which was concluded in 2019. He was a clinical adviser for Renishaw’s neuro products division for eight years and advises a number of medical device and pharma companies.​

Professor Barua has played a central role in establishing Neurochase since the company following its inception in 2020 and was appointed Chief Medical Officer in 2024.